The first national randomized trial of public Montessori preschool students showed stronger long-term outcomes by ...

Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...

Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

BERLIN -- Antibody-drug conjugates (ADCs) targeting Trop2 made a strong case as first-line standard of care for metastatic ...

A recent study found that a single dose of LSD effectively treated symptoms of anxiety for an astonishing 12 weeks.

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical ...

On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...

A recurrence risk of less than 0.5% at 6 years after surgery may provide a practical definition of “cure” in the setting of colon cancer.

With age comes wisdom. And wrinkles. And joint pain. In wellness circles, the buzz is that collagen supplements can help with ...

CheapInsurance.com reports comprehensive coverage pays for vehicle damage from animal collisions, like hitting deer.

Adjuvant cemiplimab may reduce the risk of second primary tumors in patients with high-risk cutaneous squamous cell carcinoma, data suggest.

Groundbreaking research shows that as men age, harmful genetic mutations in sperm become more common—not just from random ...